Role of silymarin as antioxidant in clinical management of chronic liver diseases: A narrative review

…, OP Alekseeva, F Angelico, IG Bakulin… - Annals of …, 2022 - Taylor & Francis
Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global
morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately—hepatocellular …

[HTML][HTML] Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease

…, RF Nasyrova, EM Krupitsky, NV Shalikiani, IG Bakulin… - Microbiome, 2017 - Springer
Background Alcohol abuse has deleterious effects on human health by disrupting the functions
of many organs and systems. Gut microbiota has been implicated in the pathogenesis of …

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a …

…, N Geyvandova, S Sleptsova, IG Bakulin… - The Lancet Infectious …, 2023 - thelancet.com
Background Bulevirtide is a first-in-class peptidic entry inhibitor for hepatitis B virus (HBV)
and hepatitis D virus infection. In July, 2020, bulevirtide 2 mg received conditional marketing …

[HTML][HTML] Comorbidities in clinical practice. Algorithms for diagnostics and treatment

…, VI Simanenkov, IG Bakulin… - Cardiovascular …, 2019 - cardiovascular.elpub.ru
IG Bakulin … Zakharova NV, Bakulin IG, Simanenkov VI, Maslygina AA. Review of the
Maastricht V / Florence consensus recommendations on the diagnosis and treatment of …

[HTML][HTML] International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”(AKTIV SARS-CoV-2): analysis of predictors of short-term adverse …

…, HG Hayrapetyan, AP Babin, IG Bakulin… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
The international AKTIV register presents a detailed description of out-and inpatients with
COVID-19 in the Eurasian region. It was found that hospitalized patients had more …

Comorbidities in practice. Clinical guidelines

…, VI Simanenkov, IG Bakulin… - Cardiovascular …, 2017 - cardiovascular.elpub.ru
IG Bakulin … Oganov RG, Denisov IN, Simanenkov VI, Bakulin IG, Bakulina NV,
Boldueva SA, Barbarash ON, Garganeeva NP, Doshchitsin VL, Drapkina OM, Dudinskaya …

[HTML][HTML] Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS …

…, HG Hayrapetyan, AP Babin, IG Bakulin… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
Aim. To study the clinical course specifics of coronavirus disease 2019 (COVID-19) and
comorbid conditions in COVID-19 survivors 3, 6, 12 months after recovery in the Eurasian region …

[HTML][HTML] International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”(AKTIV) and the register “Analysis of hospitalizations of comorbid patients …

…, HG Hayrapetyan, AP Babin, IG Bakulin… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
The organizer of the registers “Dynamics analysis of comorbidities in SARSCoV-2 survivors”(AKTIV)
and “Analysis of hospitalizations of comorbid patients infected during the second …

[HTML][HTML] Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international …

…, HG Hayrapetyan, AP Babin, IG Bakulin… - Kardiologiia, 2021 - lib.ossn.ru
… M., Rebrov AP, Tereshchenko SN, Chesnikova AI, Hayrapetyan HG, Babin AP, Bakulin IG,
Bakulina NV, Balykova LA, Blagonravova AS, Boldina MV, Vaisberg AR, Galyavich AS …

[HTML][HTML] Rehabilitation after COVID-19. Resolution of the International Expert Council of the Eurasian Association of Therapists and the Russian Society of Cardiology

AG Arutyunov, P Seferovic, IG Bakulin… - Russian journal of …, 2021 - russjcardiol.elpub.ru
By the middle of 2021, the official global number of coronavirus disease 2019 (COVID-19)
patients was close to 230 million, but the number accounting for asymptomatic patients was …